559 related articles for article (PubMed ID: 15013890)
1. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
Karacorlu M; Arf Karacorlu S; Ozdemir H
Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
[TBL] [Abstract][Full Text] [Related]
3. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
Ozdemir H; Karacorlu M; Karacorlu SA
Am J Ophthalmol; 2005 Aug; 140(2):251-5. PubMed ID: 15992756
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion.
Karacorlu M; Karacorlu SA; Ozdemir H; Senturk F
Retina; 2007 Oct; 27(8):1026-30. PubMed ID: 18040239
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
7. Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease.
Khalifa Y; Loh AR; Acharya NR
Ocul Immunol Inflamm; 2009; 17(6):431-3. PubMed ID: 20001265
[TBL] [Abstract][Full Text] [Related]
8. Tomographic features of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Maruyama Y; Kishi S
Ophthalmic Surg Lasers Imaging; 2004; 35(3):239-42. PubMed ID: 15185793
[TBL] [Abstract][Full Text] [Related]
9. Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography.
Ishihara K; Hangai M; Kita M; Yoshimura N
Ophthalmology; 2009 Sep; 116(9):1799-807. PubMed ID: 19643489
[TBL] [Abstract][Full Text] [Related]
10. Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome.
Tsujikawa A; Yamashiro K; Yamamoto K; Nonaka A; Fujihara M; Kurimoto Y
Am J Ophthalmol; 2005 Apr; 139(4):670-7. PubMed ID: 15808163
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Williamson TH; O'Donnell A
Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
[TBL] [Abstract][Full Text] [Related]
12. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
Yamaguchi Y; Otani T; Kishi S
Am J Ophthalmol; 2007 Aug; 144(2):260-5. PubMed ID: 17533104
[TBL] [Abstract][Full Text] [Related]
13. Optical coherence tomography in the acute and chronic phases of Vogt-Koyanagi-Harada disease.
Parc C; Guenoun JM; Dhote R; Brézin A
Ocul Immunol Inflamm; 2005; 13(2-3):225-7. PubMed ID: 16019683
[TBL] [Abstract][Full Text] [Related]
14. Treatment of persistent serous retinal detachment in Vogt-Koyanagi-Harada syndrome with intravitreal bevacizumab during the systemic steroid treatment.
Reibaldi M; Russo A; Avitabile T; Uva MG; Franco L; Longo A; Toro MD; Cennamo G; Mariotti C; Neri P; Noci ND; Russo V
Retina; 2014 Mar; 34(3):490-6. PubMed ID: 23903795
[TBL] [Abstract][Full Text] [Related]
15. SUB-TENON TRIAMCINOLONE ACETONIDE INJECTION IN A PREGNANT PATIENT WITH VOGT-KOYANAGI-HARADA DISEASE.
Nakamura T; Keino H; Okada AA
Retin Cases Brief Rep; 2018 Fall; 12(4):375-378. PubMed ID: 28033228
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
[TBL] [Abstract][Full Text] [Related]
20. Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.
Sivaprasad S; Ockrim Z; Massaoutis P; Ikeji F; Hykin PG; Gregor ZJ
Retina; 2008; 28(10):1435-42. PubMed ID: 18628722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
